Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Ixyldone 10mg modified-release tablets
0407020ADBTABAF
|
Ixyldone | Oxycodone hydrochloride | Central Nervous System | 36 |
|
Ixyldone 20mg modified-release tablets
0407020ADBTADAG
|
Ixyldone | Oxycodone hydrochloride | Central Nervous System | 13 |
|
Ixyldone 30mg modified-release tablets
0407020ADBTAEAR
|
Ixyldone | Oxycodone hydrochloride | Central Nervous System | 13 |
|
Ixyldone 5mg modified-release tablets
0407020ADBTAAAK
|
Ixyldone | Oxycodone hydrochloride | Central Nervous System | 12 |
|
Ixyldone 15mg modified-release tablets
0407020ADBTACAS
|
Ixyldone | Oxycodone hydrochloride | Central Nervous System | 8 |
|
Ixyldone 60mg modified-release tablets
0407020ADBTAGAQ
|
Ixyldone | Oxycodone hydrochloride | Central Nervous System | 4 |
|
Ixyldone 40mg modified-release tablets
0407020ADBTAFAH
|
Ixyldone | Oxycodone hydrochloride | Central Nervous System | 3 |
|
Ixyldone 80mg modified-release tablets
0407020ADBTAHAI
|
Ixyldone | Oxycodone hydrochloride | Central Nervous System | 2 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.